pCW57.1-DUXB-CA
(Plasmid
#125027)
-
PurposeAll-in-one lentivector with tet-inducible DUXB (codon sequences altered)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 125027 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCW57.1
- Backbone size w/o insert (bp) 9354
- Total vector size (bp) 8819
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Growth instructionsWe used Stbl3 cells (recombination deficient)
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameDUXB (codon altered)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1038
-
Mutationcodon altered
-
GenBank IDNM_001351307
-
Entrez GeneDUXB
- Promoter TRE
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site SalI (not destroyed)
- 5′ sequencing primer tcgcctggagaattggc
- 3′ sequencing primer agggctgccttggaaaag (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCW57.1-DUXB-CA was a gift from Stephen Tapscott (Addgene plasmid # 125027 ; http://n2t.net/addgene:125027 ; RRID:Addgene_125027) -
For your References section:
DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade. Chew GL, Campbell AE, De Neef E, Sutliff NA, Shadle SC, Tapscott SJ, Bradley RK. Dev Cell. 2019 Sep 9;50(5):658-671.e7. doi: 10.1016/j.devcel.2019.06.011. Epub 2019 Jul 18. 10.1016/j.devcel.2019.06.011 PubMed 31327741